Shares of Avadel (AVDL) are up $2.97, or 22%, to $16.69 near 3:10 pm ET, which is being attributed by traders to a ruling related to the company’s patent fight with Jazz Pharmaceuticals (JAZZ).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AVDL:
- Options Volatility and Implied Earnings Moves Today, March 04, 2024
- Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- Is AVDL a Buy, Before Earnings?
- Unusually active option classes on open February 29th
- Avadel Pharmaceuticals initiated with a Buy at UBS
